← Open Payments lookup

PATRICK WAINRIGHT: Open Payments

NPI 1871809004 · FOLSOM, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$179 in 10 payments from 7 companies in 2025. Trend: 2023 $443 · 2024 $148 · 2025 $179

Food & beverage: $179
CompanyPaymentsAmount
Novo Nordisk Inc3$60
Bayer Healthcare Pharmaceuticals Inc.2$40
Exact Sciences Corporation1$17
Sumitomo Pharma America, Inc.1$17
Lilly USA, LLC1$17
AstraZeneca Pharmaceuticals LP1$15
Boehringer Ingelheim Pharmaceuticals, Inc.1$14

Products named: Kerendia, Wegovy, Rybelsus, Ozempic, Cologuard Collection Kit, GEMTESA, MOUNJARO, FARXIGA.

Industry payments across LA — which companies pay providers there.